申请人:The Regents of the University of California
公开号:US11191774B2
公开(公告)日:2021-12-07
Compounds and pharmaceutical formulations containing these compounds are described. Also described are methods of making and using the compounds. The compounds include nucleobases, nucleobase analogues, or combinations thereof. In one embodiment, a nucleobase analogue is combined with doxorubicin and encapsulated within a liposome for use in inhibiting or preventing the growth of cancer cells. Further described are pharmaceutical compositions containing two or more therapeutically active agents encapsulated within a vesicle, such as a liposome, wherein the molar ratio of the agents provides a synergistic therapeutic effect.
本文描述了含有这些化合物的化合物和药物制剂。还描述了制造和使用这些化合物的方法。这些化合物包括核碱基、核碱基类似物或其组合。在一个实施方案中,核碱基类似物与多柔比星结合并封装在脂质体中,用于抑制或防止癌细胞生长。进一步描述的是含有两种或两种以上治疗活性剂的药物组合物,这些活性剂封装在脂质体等囊泡内,其中活性剂的摩尔比可提供协同治疗效果。